Found 8 matching trials
OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia PHASE1 This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer PHASE2 This phase II trial studies how well the combination of avelumab with lipos...
Show More Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Learn More & Join Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) PHASE1 This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Show More Location
UCSD Medical Center - Encinitas
Learn More & Join Trial
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing PHASE3 This Master Protocol for Avelumab Continuation Sub-Studies is to provide co...
Show More Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Learn More & Join Trial
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies PHASE1 This phase I/II trial studies the side effects of avelumab when given in di...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 PHASE1 To assess the safety and tolerability at increasing dose levels of PF-04518...
Show More Location
The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate
Learn More & Join Trial
Rituximab + Immunotherapy in Follicular Lymphoma PHASE1 This research study is studying several new investigational drug combinatio...
Show More Learn More & Join Trial
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer PHASE2 This randomized phase II trial studies how well axitinib with or without an...
Show More Status
Active Not Recruiting
Location
Los Angeles County-USC Medical Center
Learn More & Join Trial